SBIR/STTR Research Award

Ultrasound Load-Indentor for Tissue Characterization

Award identifier e4ab8793e924f788b20c591825af9bfd29b35f6c24f75b44bda9e58b009e9834Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$105,078

Program and phase

SBIR · Phase I

Award year

2001

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
DYNAMIC CONTOURS, LLC
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
Not reported
Topic code
Not reported

Research abstract

DESCRIPTION (provided by applicant): Dynamic Contours, LLC, proposes to develop an inexpensive, practical, noninvasive device for in vivo quantitative assessment of soft tissue mechanical properties, i.e. stiffness/compliance and/or stress relaxation. Quantifying the mechanical responses of tissue which has undergone pathological changes associated with various disorders has potential for use in early identification, differential diagnosis, disease staging, predicting incidence and healing rates and evaluating pharmacotherapeutic and support surface/interface interventions. Attempts to quantify such characteristics using palpation, biopsy specimens, load-indentation devices and radiological imaging techniques have failed to produce a valid method of assessing mechanical tissue properties. The Investigators have developed a novel ultrasound load-indentation device for objective assessment of buttock tissue in persons at high risk for pressure or venous ulcers. A portable version of this device appropriate for lower extremity assessment would have broad clinical and commercial application. Our short-term aims (Phase I) are to design, fabricate and evaluate a full-scale prototype of the proposed design. Long-term aims (Phase II) are the development of a pre-production prototype and beta-testing for sensitivity and specificity of the device in human subjects with venous disease and lymphedema. It is our intent to manufacture, market and distribute the device or to license the rights to a third party. PROPOSED COMMERCIAL APPLICATION: This device has the potential to replace high risk, expensive diagnostic techniques and improve diagnosis and treatment in pathologies affecting the soft tissues. It will be used to aid in early detection and differential diagnosis as well as to monitor outcomes of therapeutic interventions. There are currently no practical clinical tools on the market to directly measure soft tissue properties for use in diagnosing various pathological conditions.

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.